Report Detail
Global Glimepiride Market Insights, Forecast to 2025
- RnM3663470 |
- 13 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Glimepiride is a member of the second-generation sulfonylurea (SU) drug class used for the management of type 2 diabetes mellitus (T2DM) to improve glycemic control. Type 2 diabetes is a metabolic disorder with increasing prevalences worldwide; it is characterized by insulin resistance in accordance with progressive β cell failure and long-term microvascular and macrovascular complications that lead to co-morbidities and mortalities. Sulfonylureas are one of the insulin secretagogues widely used for the management of type 2 diabetes to lower blood glucose levels. The main effect of SUs is thought to be effective when residual pancreatic β-cells are present 3, as they work by stimulating the release of insulin from the pancreatic beta cells and they are also thought to exert extra-pancreatic effects, such as increasing the insulin-mediated peripheral glucose uptake
The global Glimepiride market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glimepiride market based on company, product type, end user and key regions.
This report studies the global market size of Glimepiride in key regions like North America, Europe, China and Japan, focuses on the consumption of Glimepiride in these regions.
This research report categorizes the global Glimepiride market by top players/brands, region, type and end user. This report also studies the global Glimepiride market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Physicians Total Care, Inc
Apotex
Sandoz
Avera
St. Marys
RemedyRepack
Perrigo
CorePharma LLC
Glaxosmithkline Inc
Glimepiride market size by Type
Capsule
Sheet
Glimepiride market size by Applications
Basic Science
Cure
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Glimepiride market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glimepiride market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glimepiride companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glimepiride submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Glimepiride are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glimepiride market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Glimepiride Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Glimepiride Market Size Growth Rate by Type
- 1.4.2 Capsule
- 1.4.3 Sheet
- 1.5 Market by Application
- 1.5.1 Global Glimepiride Market Size Growth Rate by Application
- 1.5.2 Basic Science
- 1.5.3 Cure
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Glimepiride Market Size
- 2.1.1 Global Glimepiride Revenue 2014-2025
- 2.1.2 Global Glimepiride Sales 2014-2025
- 2.2 Glimepiride Growth Rate by Regions
- 2.2.1 Global Glimepiride Sales by Regions
- 2.2.2 Global Glimepiride Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Glimepiride Sales by Manufacturers
- 3.1.1 Glimepiride Sales by Manufacturers
- 3.1.2 Glimepiride Sales Market Share by Manufacturers
- 3.2 Glimepiride Revenue by Manufacturers
- 3.2.1 Glimepiride Revenue by Manufacturers (2014-2019)
- 3.2.2 Glimepiride Revenue Share by Manufacturers (2014-2019)
- 3.3 Glimepiride Price by Manufacturers
- 3.4 Glimepiride Manufacturing Base Distribution, Product Types
- 3.4.1 Glimepiride Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Glimepiride Product Type
- 3.4.3 Date of International Manufacturers Enter into Glimepiride Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Glimepiride Sales by Type
- 4.2 Global Glimepiride Revenue by Type
- 4.3 Glimepiride Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Glimepiride Breakdown Data by Application
6 North America
- 6.1 North America Glimepiride by Country
- 6.1.1 North America Glimepiride Sales by Country
- 6.1.2 North America Glimepiride Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Glimepiride by Type
- 6.3 North America Glimepiride by Application
7 Europe
- 7.1 Europe Glimepiride by Country
- 7.1.1 Europe Glimepiride Sales by Country
- 7.1.2 Europe Glimepiride Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Glimepiride by Type
- 7.3 Europe Glimepiride by Application
8 Asia Pacific
- 8.1 Asia Pacific Glimepiride by Region
- 8.1.1 Asia Pacific Glimepiride Sales by Region
- 8.1.2 Asia Pacific Glimepiride Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
- 8.2 Asia Pacific Glimepiride by Type
- 8.3 Asia Pacific Glimepiride by Application
9 Central & South America
- 9.1 Central & South America Glimepiride by Country
- 9.1.1 Central & South America Glimepiride Sales by Country
- 9.1.2 Central & South America Glimepiride Revenue by Country
- 9.1.3 Brazil
- 9.2 Central & South America Glimepiride by Type
- 9.3 Central & South America Glimepiride by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Glimepiride by Country
- 10.1.1 Middle East and Africa Glimepiride Sales by Country
- 10.1.2 Middle East and Africa Glimepiride Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Glimepiride by Type
- 10.3 Middle East and Africa Glimepiride by Application
11 Company Profiles
- 11.1 Sanofi
- 11.1.1 Sanofi Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sanofi Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sanofi Glimepiride Products Offered
- 11.1.5 Sanofi Recent Development
- 11.2 Physicians Total Care, Inc
- 11.2.1 Physicians Total Care, Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Physicians Total Care, Inc Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Physicians Total Care, Inc Glimepiride Products Offered
- 11.2.5 Physicians Total Care, Inc Recent Development
- 11.3 Apotex
- 11.3.1 Apotex Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Apotex Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Apotex Glimepiride Products Offered
- 11.3.5 Apotex Recent Development
- 11.4 Sandoz
- 11.4.1 Sandoz Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sandoz Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sandoz Glimepiride Products Offered
- 11.4.5 Sandoz Recent Development
- 11.5 Avera
- 11.5.1 Avera Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Avera Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Avera Glimepiride Products Offered
- 11.5.5 Avera Recent Development
- 11.6 St. Marys
- 11.6.1 St. Marys Company Details
- 11.6.2 Company Business Overview
- 11.6.3 St. Marys Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 St. Marys Glimepiride Products Offered
- 11.6.5 St. Marys Recent Development
- 11.7 RemedyRepack
- 11.7.1 RemedyRepack Company Details
- 11.7.2 Company Business Overview
- 11.7.3 RemedyRepack Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 RemedyRepack Glimepiride Products Offered
- 11.7.5 RemedyRepack Recent Development
- 11.8 Perrigo
- 11.8.1 Perrigo Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Perrigo Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Perrigo Glimepiride Products Offered
- 11.8.5 Perrigo Recent Development
- 11.9 CorePharma LLC
- 11.9.1 CorePharma LLC Company Details
- 11.9.2 Company Business Overview
- 11.9.3 CorePharma LLC Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 CorePharma LLC Glimepiride Products Offered
- 11.9.5 CorePharma LLC Recent Development
- 11.10 Glaxosmithkline Inc
- 11.10.1 Glaxosmithkline Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Glaxosmithkline Inc Glimepiride Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Glaxosmithkline Inc Glimepiride Products Offered
- 11.10.5 Glaxosmithkline Inc Recent Development
12 Future Forecast
- 12.1 Glimepiride Market Forecast by Regions
- 12.1.1 Global Glimepiride Sales Forecast by Regions 2019-2025
- 12.1.2 Global Glimepiride Revenue Forecast by Regions 2019-2025
- 12.2 Glimepiride Market Forecast by Type
- 12.2.1 Global Glimepiride Sales Forecast by Type 2019-2025
- 12.2.2 Global Glimepiride Revenue Forecast by Type 2019-2025
- 12.3 Glimepiride Market Forecast by Application
- 12.4 North America Glimepiride Forecast
- 12.5 Europe Glimepiride Forecast
- 12.6 Asia Pacific Glimepiride Forecast
- 12.7 Central & South America Glimepiride Forecast
- 12.8 Middle East and Africa Glimepiride Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Glimepiride Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Glimepiride. Industry analysis & Market Report on Glimepiride is a syndicated market report, published as Global Glimepiride Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Glimepiride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
